Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi: 10.1210/en.136.10.4629 39 ThorensBWidmannC
The upcoming TRIUMPH-Outcomes trial, enrolling 10,000 patients, will eventually provide the kind of multi-year data that transforms confidence in long-term safety
The early trial data is striking, and people want access now
Discovery of a novel series of orally bioavailable and CNS penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) non-competitive antagonists based on a 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione core
US$ 29.76
US$ 25.17
US$ 28.57
